-
公开(公告)号:US20100168430A1
公开(公告)日:2010-07-01
申请号:US11997967
申请日:2006-08-04
申请人: Sawako Ozawa , Nobuhiro Oikawa , Eisaku Mizuguchi , Hirosato Ebiike , Fumio Watanabe , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi , Yasuhiro Tamaki , Hidenori Takahashi
发明人: Sawako Ozawa , Nobuhiro Oikawa , Eisaku Mizuguchi , Hirosato Ebiike , Fumio Watanabe , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi , Yasuhiro Tamaki , Hidenori Takahashi
IPC分类号: C07D471/04
CPC分类号: C07D471/04
摘要: It is intended to provide a compound represented by the formula (1): [wherein Ar is an arylene group to be attached selected from the following formula (2): (wherein * represents a binding site to a nitrogen atom and ** represents a binding site to T); T represents —(O)n—R; R represents a C1-C6 alkyl group or the like; n represents 0 or 1; X represents O or the like; R2, R3 and R4 are independently selected from a hydrogen atom or C1-C3 alkyl; or R2 and R3 may join together with an urea structure containing the nitrogen atoms to which they bind to form a 5- or 6-membered heterocycle; Y represents CH or N], or a pharmaceutically acceptable salt thereof or a prodrug thereof and a pharmaceutical composition containing the same.
摘要翻译: 旨在提供由式(1)表示的化合物:[其中Ar是选自下式(2)中的被连接的亚芳基:(其中*表示与氮原子的结合位点,**表示 结合位点到T); T表示 - (O)n -R; R表示C1-C6烷基等; n表示0或1; X表示O等; R2,R3和R4独立地选自氢原子或C1-C3烷基; 或者R 2和R 3可以与含有它们所结合的氮原子的脲结合物一起形成5-或6-元杂环; Y表示CH或N],或其药学上可接受的盐或其前药,以及含有该化合物的药物组合物。
-
公开(公告)号:US08299252B2
公开(公告)日:2012-10-30
申请号:US11997967
申请日:2006-08-04
申请人: Sawako Ozawa , Nobuhiro Oikawa , Eisaku Mizuguchi , Hirosato Ebiike , Fumio Watanabe , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi
发明人: Sawako Ozawa , Nobuhiro Oikawa , Eisaku Mizuguchi , Hirosato Ebiike , Fumio Watanabe , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi
IPC分类号: A61K31/437 , C07D471/04
CPC分类号: C07D471/04
摘要: It is intended to provide a compound represented by the formula (1): [wherein Ar is an arylene group to be attached selected from the following formula (2): (wherein * represents a binding site to a nitrogen atom and ** represents a binding site to T); T represents —(O)n—R; R represents a C1-C6 alkyl group or the like; n represents 0 or 1; X represents O or the like; R2, R3 and R4 are independently selected from a hydrogen atom or C1-C3 alkyl; or R2 and R3 may join together with an urea structure containing the nitrogen atoms to which they bind to form a 5- or 6-membered heterocycle; Y represents CH or N], or a pharmaceutically acceptable salt thereof or a prodrug thereof and a pharmaceutical composition containing the same.
摘要翻译: 旨在提供由式(1)表示的化合物:[其中Ar是选自下式(2)中的被连接的亚芳基:(其中*表示与氮原子的结合位点,**表示 结合位点到T); T表示 - (O)n -R; R表示C1-C6烷基等; n表示0或1; X表示O等; R2,R3和R4独立地选自氢原子或C1-C3烷基; 或者R 2和R 3可以与含有它们所结合的氮原子的脲结合物一起形成5-或6-元杂环; Y表示CH或N],或其药学上可接受的盐或其前药,以及含有该化合物的药物组合物。
-
公开(公告)号:US08609656B2
公开(公告)日:2013-12-17
申请号:US10590026
申请日:2005-02-23
申请人: Nobuhiro Oikawa , Eisaku Mizuguchi , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi , Sawako Ozawa
发明人: Nobuhiro Oikawa , Eisaku Mizuguchi , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi , Sawako Ozawa
IPC分类号: A61K31/535
CPC分类号: C07D209/08 , C07D209/32 , C07D209/40 , C07D209/42 , C07D235/06 , C07D413/04 , C07D417/12 , C07D471/04 , C07D473/00 , C07D473/34 , C07D473/40
摘要: The present invention provides a compound represented by the formula (1): wherein R1, R2 and R5 are each independently selected from a hydrogen atom, a halogen atom, a C1-C6 alkyl is substituted with a halogen atom and the like; R3 and R4 are each independently selected from a hydrogen atom, a halogen atom, a substituted C1-C6 alkyl group and the like; R6 and R7 are each independently selected from a hydrogen atom and a halogen atom; Z1 and Z2 are each independently selected from a hydrogen atom, a hydroxyl group and —O(CHR11)OC(═O)R12; Q is a group of the formula: (wherein G1 is C—Y2 or N; a ring A is a benzene ring or a 5- to 6-membered unsaturated heterocycle) a pharmaceutically acceptable salt thereof or a prodrug thereof.
摘要翻译: 本发明提供由式(1)表示的化合物:其中R1,R2和R5各自独立地选自氢原子,卤素原子,C1-C6烷基被卤素原子等取代; R 3和R 4各自独立地选自氢原子,卤素原子,取代的C 1 -C 6烷基等; R6和R7各自独立地选自氢原子和卤素原子; Z 1和Z 2各自独立地选自氢原子,羟基和-O(CHR 11)OC(= O)R 12; Q是下式的基团:其中G1是C-Y2或N;环A是苯环或5-至6-元不饱和杂环)其药学上可接受的盐或其前药。
-
公开(公告)号:US20080119466A1
公开(公告)日:2008-05-22
申请号:US10590026
申请日:2005-02-23
申请人: Nobuhiro Oikawa , Eisaku Mizuguchi , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi , Sawako Ozawa
发明人: Nobuhiro Oikawa , Eisaku Mizuguchi , Kenji Morikami , Nobuo Shimma , Nobuya Ishii , Toshiyuki Tsukaguchi , Sawako Ozawa
IPC分类号: A61K31/5377 , A61K31/404 , A61K31/4184 , A61K31/437 , A61P29/00 , A61P35/00 , C07D209/04 , C07D413/12 , C07D473/00 , C07D471/04 , C07D235/04 , A61P9/10 , A61P3/10 , A61P17/06 , A61K31/496 , A61K31/52
CPC分类号: C07D209/08 , C07D209/32 , C07D209/40 , C07D209/42 , C07D235/06 , C07D413/04 , C07D417/12 , C07D471/04 , C07D473/00 , C07D473/34 , C07D473/40
摘要: The present invention provides a compound represented by the formula (1): wherein R1, R2 and R5 are each independently selected from a hydrogen atom, a halogen atom, a C1-C6 alkyl is substituted with a halogen atom and the like; R3 and R4 are each independently selected from a hydrogen atom, a halogen atom, a substituted C1-C6 alkyl group and the like; R6 and R7 are each independently selected from a hydrogen atom and a halogen atom; Z1 and Z2 are each independently selected from a hydrogen atom, a hydroxyl group and —O(CHR11)OC(═O)R12; Q is a group of the formula: (wherein G1 is C—Y2 or N; a ring A is a benzene ring or a 5- to 6-membered unsaturated heterocycle) a pharmaceutically acceptable salt thereof or a prodrug thereof.
摘要翻译: 本发明提供由式(1)表示的化合物:其中R 1,R 2和R 5各自独立地选自 氢原子,卤素原子,C 1 -C 6 - 烷基被卤素原子等取代; R 3和R 4各自独立地选自氢原子,卤素原子,取代的C 1 -C 6烷基, 烷基等; R 6和R 7各自独立地选自氢原子和卤素原子; Z 1和Z 2各自独立地选自氢原子,羟基和-O(CHR 11)OC(-O) R 12; Q是下式的基团:(其中G 1是CH 2或N;环A是苯环或5-至6-元不饱和杂环) 其药学上可接受的盐或其前药。
-
公开(公告)号:US07820693B2
公开(公告)日:2010-10-26
申请号:US11816910
申请日:2006-02-22
申请人: Kazuo Hattori , Satoshi Niizuma , Miyako Masubuchi , Kohei Koyama , Osamu Kondoh , Toshiyuki Tsukaguchi , Takehiro Okada
发明人: Kazuo Hattori , Satoshi Niizuma , Miyako Masubuchi , Kohei Koyama , Osamu Kondoh , Toshiyuki Tsukaguchi , Takehiro Okada
IPC分类号: A61K31/47 , C07D401/10
CPC分类号: C07D491/04 , C07D401/04 , C07D401/14 , C07D413/04 , C07D413/14
摘要: The present invention provides a compound having high antitumor activity, which is useful for therapeutic and preventive agents effective for proliferative diseases such as cancer; a production method thereof; an intermediate compound useful for such production; and a pharmaceutical composition comprising such a compound. The present invention provides a compound represented by the formula (1): wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt thereof; and a pharmaceutical and a pharmaceutical composition which comprise the compound.
摘要翻译: 本发明提供具有高抗肿瘤活性的化合物,其可用于对增殖性疾病如癌症有效的治疗和预防剂; 其制造方法; 用于这种生产的中间体化合物; 和包含这种化合物的药物组合物。 本发明提供由式(1)表示的化合物:其中X表示可被取代的芳基或杂芳基,Cy表示4-至7-元单环杂环或8-至10-元稠合杂环 可以被取代的环,Z表示O,S或NRa; 或其前药; 或其药学上可接受的盐; 以及包含该化合物的药物和药物组合物。
-
公开(公告)号:US20090030195A1
公开(公告)日:2009-01-29
申请号:US11816910
申请日:2006-02-22
申请人: Kazuo Hattori , Satoshi Niizuma , Miyako Masubuchi , Kohei Koyama , Osamu Kondoh , Toshiyuki Tsukaguchi , Takehiro Okada
发明人: Kazuo Hattori , Satoshi Niizuma , Miyako Masubuchi , Kohei Koyama , Osamu Kondoh , Toshiyuki Tsukaguchi , Takehiro Okada
IPC分类号: C07D401/10 , C07D413/10
CPC分类号: C07D491/04 , C07D401/04 , C07D401/14 , C07D413/04 , C07D413/14
摘要: The present invention provides a compound having high antitumor activity, which is useful for therapeutic and preventive agents effective for proliferative diseases such as cancer; a production method thereof; an intermediate compound useful for such production; and a pharmaceutical composition comprising such a compound. The present invention provides a compound represented by the formula (1): wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt thereof; and a pharmaceutical and a pharmaceutical composition which comprise the compound.
摘要翻译: 本发明提供具有高抗肿瘤活性的化合物,其可用于对增殖性疾病如癌症有效的治疗和预防剂; 其制造方法; 用于这种生产的中间体化合物; 和包含这种化合物的药物组合物。 本发明提供由式(1)表示的化合物:其中X表示可被取代的芳基或杂芳基,Cy表示4-至7-元单环杂环或8-至10-元稠合杂环 可以被取代的环,Z表示O,S或NRa; 或其前药; 或其药学上可接受的盐; 以及包含该化合物的药物和药物组合物。
-
公开(公告)号:US08420668B2
公开(公告)日:2013-04-16
申请号:US13131422
申请日:2009-11-27
申请人: Kazuo Hattori , Takehiro Okada , Osamu Kondoh , Toshiyuki Tsukaguchi , Masaki Shibata , Satoshi Tanida
发明人: Kazuo Hattori , Takehiro Okada , Osamu Kondoh , Toshiyuki Tsukaguchi , Masaki Shibata , Satoshi Tanida
IPC分类号: C07D413/04 , A61K31/47
CPC分类号: C07F9/65583 , A61K9/0019
摘要: The present invention provides a compound of the formula (I) or a pharmaceutically acceptable salt thereof:
摘要翻译: 本发明提供式(I)化合物或其药学上可接受的盐:
-
公开(公告)号:US20110282062A1
公开(公告)日:2011-11-17
申请号:US13131422
申请日:2009-11-27
申请人: Kazuo Hattori , Takehiro Okada , Osamu Kondoh , Toshiyuki Tsukaguchi , Masaki Shibata , Satoshi Tanida
发明人: Kazuo Hattori , Takehiro Okada , Osamu Kondoh , Toshiyuki Tsukaguchi , Masaki Shibata , Satoshi Tanida
IPC分类号: C07F9/06
CPC分类号: C07F9/65583 , A61K9/0019
摘要: The present invention provides a compound of the formula (I) or a pharmaceutically acceptable salt thereof:
摘要翻译: 本发明提供式(I)化合物或其药学上可接受的盐:
-
-
-
-
-
-
-